Barely Significant
← all excerpts

Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer.

ESMO Open · 2021 · PMC8041717 · PMID 33780892

Europe PMCDOI
1
hedged sentence
0.1370
closest p · 2.7× alpha
0.1370
boldest claim

The sentences

did not reach statistical significanceP = 0.137not close (p > 0.1)
The association between the combined timing of treatment and OS did not reach statistical significance ( P = 0.137) in the univariate analyses, likely due to the small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.